These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18240852)

  • 1. Long-term safety of stimulant medications used to treat children with ADHD.
    Lerner M; Wigal T
    Pediatr Ann; 2008 Jan; 37(1):37-45. PubMed ID: 18240852
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADHD: monitoring for and managing stimulant adverse effects.
    Mercer M; Farver D
    S D Med; 2013 Dec; 66(12):511, 513. PubMed ID: 24527549
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of stimulant medications in children with attention-deficit/hyperactivity disorder.
    Adesman AR; Morgan AM
    Pediatr Clin North Am; 1999 Oct; 46(5):945-63, vii-viii. PubMed ID: 10570698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of stimulant medications for ADHD.
    Natl Bur Econ Res Bull Aging Health; 2014; (1):1-2. PubMed ID: 25141389
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse effects of stimulant medications in children and adolescents: focus on sleep and growth disturbances.
    Greydanus DE; Cates KW; Sadigh N
    Int J Adolesc Med Health; 2019 May; 31(2):. PubMed ID: 31079090
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term safety of stimulant medications used to treat children with ADHD.
    Lerner M; Wigal T
    J Psychosoc Nurs Ment Health Serv; 2008 Aug; 46(8):38-48. PubMed ID: 18777967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children.
    August GJ; Realmuto GM
    Minn Med; 2000 Jun; 83(6):45-6. PubMed ID: 10881573
    [No Abstract]   [Full Text] [Related]  

  • 9. Getting to Long-Term Effectiveness and Safety of Attention-deficit Hyperactivity Disorder Medications.
    Beau-Lejdstrom R; Zito JM
    Clin Pharmacol Ther; 2018 Oct; 104(4):610-612. PubMed ID: 30120774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.
    Merkel RL
    Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant medications.
    Greenhill LL; Halperin JM; Abikoff H
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):503-12. PubMed ID: 10230181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.
    Froehlich TE; Fogler J; Barbaresi WJ; Elsayed NA; Evans SW; Chan E
    Clin Pharmacol Ther; 2018 Oct; 104(4):619-637. PubMed ID: 30053315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNS stimulant controversies.
    Levy F
    Aust N Z J Psychiatry; 1989 Dec; 23(4):497-502. PubMed ID: 2575372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant medication for the child with attention-deficit/hyperactivity disorder.
    Bennett FC; Brown RT; Craver J; Anderson D
    Pediatr Clin North Am; 1999 Oct; 46(5):929-44, vii. PubMed ID: 10570697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
    Hammerness PG; Karampahtsis C; Babalola R; Alexander ME
    Expert Opin Drug Saf; 2015 Apr; 14(4):543-51. PubMed ID: 25648243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children don't think that stimulant drugs for ADHD rob them of their "authenticity" and moral responsibility.
    Kmietowicz Z
    BMJ; 2012 Oct; 345():e6947. PubMed ID: 23071287
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.
    Hechtman L; Greenfield B
    Paediatr Drugs; 2003; 5(12):787-94. PubMed ID: 14658920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2012 Mar; 50(3):11-2. PubMed ID: 22390784
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B; Towbin K
    Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.